• 한국식품과학회지
• /
• 제35권5호
• /
• pp.924-927
• /
• 2003

비피더스 균주가 가지고 있는 여러 생리 활성을 나타내는 부가가치를 부여한 새로운 고기능성 심치 제품을 개발하기 위해 편성 혐기성 미생물인 비피더스균 가운데 산소에 내성이 있는 Bifidobacterium lactis를 선발하여 김치 제조에 적용하였다. 이 균주의 내산성과 내염성을 각각 알아본 결과 pH 30에서는 별다른 영향을 받지 않았으며 pH 2.5에서도 50% 이상의 생존율을 나타내었다. 그리고 NaCl 농도 3.5%에서도 사멸하지 않는 것으로 나타나 일반적인 김치의 pH와 염농도를 고려할 때 김치에 적용 가능한 것으로 판단되었다. 첨가된 Bifidobacterium lactis가 김치 내에서 생존함을 확인하기 위해서 PCR을 이용하여 확인한 결과 15일 이상 생존하고 있음을 확인할 수 있었다. 그리고 관능평가의 경우 Bifidobacterium lactis 첨가 김치가 전체적인 기호도에서 균주를 첨가하지 않은 대조군 김치와 유사한 특성을 나타냄으로써 Bifidobacterium lactis를 이용한 고기능성 김치의 제조가 가능할 것으로 판단되었다.

• Journal of Microbiology and Biotechnology
• /
• 제22권12호
• /
• pp.1714-1723
• /
• 2012

${\beta}$-Glucosidase is necessary for the bioconversion of glycosidic phytochemicals in food. Two Bifidobacterium strains (Bifidobacterium animalis subsp. lactis SH5 and B. animalis subsp. lactis RD68) with relatively high ${\beta}$-glucosidase activities were selected among 46 lactic acid bacteria. A ${\beta}$-glucosidase gene (bbg572) from B. lactis was shotgun cloned, fully sequenced, and analyzed for its transcription start site, structural gene, and deduced transcriptional terminator. The structural gene of bbg572 was 1,383 bp. Based on amino sequence similarities, bbg572 was assigned to family 1 of the glycosyl hydrolases. To overexpress bbg572 in Bifidobacterium, several bifidobacteria expression vectors were constructed by combining several promoters and a terminator sequence from different bifidobacteria. The maximum activity of recombinant Bbg572 was achieved when it was expressed under its own promoter and terminator. Its enzyme activity increased 31-fold compared with those of its parental strains. The optimal pH for Bbg572 was pH 6.0. Bbg572 was stable at $37-40^{\circ}C$. It hydrolyzed isoflavones, quercetins, and disaccharides with various ${\beta}$-glucoside linkages. Bbg572 also converted the ginsenosides Rb1 and Rb2. These results suggest that this new ${\beta}$-glucosidase-positive Bifidobacterium transformant can be utilized for the production of specific aglycone products.

• Preventive Nutrition and Food Science
• /
• 제16권4호
• /
• pp.386-389
• /
• 2011

Previous studies have confirmed that fermented whey produced by Leuconostoc mesenteroides CJNU 0147 or Lactobacillus casei CJNU 0588 display bifidogenic growth stimulator (BGS) activity. The present study sought to determine if the strain itself can improve the growth of bifidobacteria in co-cultures. In reinforced clostridial medium (RCM), both strains stimulated the growth of a Bifidobacterium lactis strain during the exponential phase and also stimulated the growth during almost all growth phases in whey broth. Fermented whey containing viable Leu. mesenteroides CJNU 0147 and L. casei CJNU 0588 cells maintained viability of the B. lactis strain stored at $10^{\circ}C$ in MRS broth. Viable cell count of the B. lactis strain without the fermented whey was decreased to 5.6 log cfu/mL after 15 days, whereas that of the strain with the fermented whey was slightly increased to 7.1 log cfu/mL as compared with initial viable cell count of 6.9 log cfu/mL.

• Journal of Applied Biological Chemistry
• /
• 제53권3호
• /
• pp.126-131
• /
• 2010

대두가공공정 중 발생하는 부산물인 대두배아 및 대두 단백질을 이용하여 Bifidobacterium lactis BL740의 생균수 및 대두 이소플라본 비배당체 생산 최대화를 위한 배지최적화를 수행하였고 이를 위하여 통계적 방법인 fractional factorial design (FFD) 및 central composite design(CCD)를 이용, 대두 유래 성분들이 포함된 배지 (S-medium)의 최적 조성물을 확언하였다. FFD의 경우 glucose, cellobiose, fructooligosaccharidde, soy peptone, soy protein, 대두배아를 이용 총 6가지 요소를 2수준에서 적용하였으며 이 중 soy protein, soy peptone 그리고 대두 배아가 B. lactis BL740의 균성장 혹은 대두 이소플라본 비배당체 전환에 중요 인자로 확인이 되었다. FFD에서 확인된 3가지 인자를 CCD에 적용하였으며 이를 통해 균성장의 경우 최적의 배지조성함량이 soy peptone 29.55 g/L, soy protein 12.73 g/L, 대두 배아 130.67 g/L로 확인되었으며 비배당체 전환의 경우 soy peptone 1.25 g/L, soy protein 2.06 g/L, 대두 배아 60.02 g/L로 최적화 되었다.

• Journal of Animal Science and Technology
• /
• 제63권3호
• /
• pp.603-613
• /
• 2021

This research improved the growth potential of Bifidobacterium animalis subsp lactis strain JNU306, a commercial medium that is appropriate for large-scale production, in yeast extract, soy peptone, glucose, L-cysteine, and ferrous sulfate. Response surface methodology (RSM) was used to optimize the components of this medium, using a central composite design and subsequent analyses. A second-order polynomial regression model, which was fitted to the data at first, significantly lacked fitness. Thus, through further analyses, the model with linear and quadratic terms plus two-way, three-way, and four-way interactions was selected as the final model. Through this model, the optimized medium composition was found as 2.8791% yeast extract, 2.8030% peptone soy, 0.6196% glucose, 0.2823% L-cysteine, and 0.0055% ferrous sulfate, w/v. This optimized medium ensured that the maximum biomass was no lower than the biomass from the commonly used blood-liver (BL) medium. The application of RSM improved the biomass production of this strain in a more cost-effective way by creating an optimum medium. This result shows that B. animalis subsp lactis JNU306 may be used as a commercial starter culture in manufacturing probiotics, including dairy products.

• 미생물학회지
• /
• 제40권1호
• /
• pp.37-42
• /
• 2004

현재 상업적으로 이용되고 있는 비피더스균인 Bifidobacterium lactis Bb-12, Bif. longum Bb-536 및 Bif. infantis Maeil-K9의 선택적 계수를 위한 선택배지 개발을 위하여 다양한 탄소원과 질소원 및 여러 항생제들에 대한 내성을 검토하였다. 탄소원의 경우 기본생육배지에 각각 15 g/L 수준으로 첨가하여 각균주의 생육성을 비교해 본 결과 amygdalin과 fructose가 가장 적합하였으며, 질소원의 경우 tryptone이 가장 적합한 것으로 나타났다. Amygdalin을 탄소원으로 이용한 경우 Bif. lactis Bb-12와 Bif. infantis Maeil-K9의 생육성이 우수하였으며, fructose를 이용한 경우 Bif. longum Bb-536의 생육성이 우수하였다. 항생제 내성 검토에 있어서는 doxycyclin을 1 mg/L 수준으로 첨가하는 것이 가장 적절하였으며, Bif. lactis Bb-12및 Bif. infantis Maeil-K9의 생육에는 전혀 영향을 주지 않았으나, Bif. longum Bb-536의 생육은 완전히 억제시켰다. 그리고 저 활성 균주에 대한 각 선택 배지의 검출능을 알아보기 위하여 각균주를 -$70^{\circ}C$, $4^{\circ}C$, $40^{\circ}C$에 2주간 보존 후 생균수를 측정한 결과 amygdalin을 탄소원으로 이용한 배지에서는 $40^{\circ}C$ 보존균주의 검출능이 낮았으나, fructose를 탄소원으로 이용한 배지와 doxycyclin을 첨가한 배지의 경우 그 선택성이 매우 우수하였다.

• Journal of Microbiology and Biotechnology
• /
• 제18권8호
• /
• pp.1393-1400
• /
• 2008

Recent study has demonstrated an increasing prevalence of food allergy in Korean children. Specific probiotic bacteria may promote potentially anti-allergenic processes through induction of Th1-type immunity and enhance the regulatory lymphocyte. This study investigated whether orally administrated probiotics could suppress allergic responses in an ovalbumin (OVA)-induced allergy mouse model. Thus, female C3H/HeJ mice were orally sensitized with OVA and cholera toxin for 4 weeks. Lactobacillus acidophilus AD031, Bifidobacterium lactis AD011, and L. acidophilus AD031 plus B. lactis AD011 were fed to mice from 2 weeks before the sensitization. The OVA-induced mice that were not treated with probiotics had significantly increased serum levels of OVA-specific IgE and IgG1, and OVA-specific IgA in feces. However, the mice treated with probiotics suppressed production of the OVA-specific IgE, IgG1, and IgA. The level of IL-4 was significantly lower, and the levels of INF-$\gamma$ and IL-10 were significantly higher in the mice treated with probiotics than that in the non-treated mice. The groups treated with probiotics had decreased levels of degranulated mast cells, eosinophil granules, and tail scabs. These results indicate that L. acidophilus AD031 and B. lactis AD011 might be useful for the prevention of allergy.

• Journal of Microbiology and Biotechnology
• /
• 제21권8호
• /
• pp.838-845
• /
• 2011

The present work describes the identification, purification, and characterization of bile salt hydrolase (BSH) from Bifidobacterium animalis subsp. lactis. The enzyme was purified to electrophoretic homogeneity by hydrophobic chromatography, ion-exchange chromatography and ultrafiltration. SDS-PAGE analysis of putative BSH and gel filtration revealed that the analyzed protein is presumably a tetramer composed of four monomers each of about 35 kDa. The purified enzyme was analyzed by liquid chromatography coupled to LTQ FT ICR mass spectrometry and unambiguously identified as a bile salt hydrolase from B. animalis. The isoelectric point of the studied protein was estimated to be around pH 4.9. The pH optimum of the purified BSH is between 4.7 to 6.5, and the temperature optimum is around 50oC. The BSH of B. animalis could deconjugate all tested bile salts, with clear preference for glycine-conjugated bile salts over taurine-conjugated forms. Genetic analysis of the bsh showed high similarity to the previously sequenced bsh gene from B. animalis and confirmed the usefulness of bile salt hydrolase as a genetic marker for B. animalis identification.

• Journal of Microbiology and Biotechnology
• /
• 제32권9호
• /
• pp.1146-1153
• /
• 2022

Many probiotic species have been used as a fermentation starter for manufacturing functional food materials. We have isolated Bifidobacterium animalis subsp. lactis LDTM 8102 from the feces of infants as a novel strain for fermentation. While Glycine max has been known to display various bioactivities including anti-oxidant, anti-skin aging, and anti-cancer effects, the immune-modulatory effect of Glycine max has not been reported. In the current study, we have discovered that the extract of Glycine max fermented with B. animalis subsp. lactis LDTM 8102 (GFB 8102), could exert immuno-modulatory properties. GFB 8102 treatment increased the production of immune-stimulatory cytokines in RAW264.7 macrophages without any noticeable cytotoxicity. Analysis of the molecular mechanism revealed that GFB 8102 could upregulate MAPK2K and MAPK signaling pathways including ERK, p38, and JNK. GFB 8102 also increased the proliferation rate of splenocytes isolated from mice. In an animal study, administration of GFB 8102 partially recovered cyclophosphamide-mediated reduction in thymus and spleen weight. Moreover, splenocytes from the GFB 8102-treated group exhibited increased TNF-α, IL-6, and IL-1β production. Based on these findings, GFB 8102 could be a promising functional food material for enhancing immune function.

• Journal of Microbiology and Biotechnology
• /
• 제30권6호
• /
• pp.885-892
• /
• 2020

Chemotherapy regimens for non-small cell lung cancer (NSCLC) have various adverse effects on the human body. For this reason, probiotics have received attention regarding their potential value as a safe and natural complementary strategy for cancer prevention. This study analyzed the anticancer effects of aqueous extracts of probiotic bacteria Bifidobacterium bifidum (BB), Bifidobacterium longum (BL), Bifidobacterium lactis (BLA), Bifidobacterium infantis 1 (BI1), and Bifidobacterium infantis 2 (BI2) on NSCLC cell lines. When the aqueous extracts of probiotic Bifidobacterium species were applied to the NSCLC cell lines A549, H1299, and HCC827, cell death increased considerably; in particular, the aqueous extracts from BB and BLA markedly reduced cell proliferation. p38 phosphorylation induced by BB aqueous extract increased the expression of cleaved caspase 3 and cleaved poly (ADP-ribose) polymerase (PARP), consequently inducing the apoptosis of A549 and H1299 cells. When the p38 inhibitor SB203580 was applied, phosphorylation of p38 decreased, and the expression of cleaved caspase 3 and cleaved PARP was also inhibited, resulting in a reduction of cell death. In addition, BB aqueous extracts reduced the secretion of MMP-9, leading to inhibition of cancer cell invasion. By contrast, after transfection of short hairpin RNA shMMP-9 (for a knockdown of MMP-9) into cancer cells, BB aqueous extracts treatment failed to suppress the cancer cell invasiveness. According to our results about their anticancer effects on NSCLC, probiotics consisting of Bifidobacterium species may be useful as adjunctive anticancer treatment in the future.